Document is current
Any future updates will be listed below
-
Authors
Hamati, Rami https://orcid.org/0000-0001-7213-9253
Kanaa, Nour
Chidiac, Bianca
Guimond, Synthia https://orcid.org/0000-0002-1582-725X
Cassidy, Clifford
Tuominen, Lauri
-
Funding
Funding for this research was provided by:
Brain and Behavior Research Foundation
Gouvernement du Canada | Canadian Institutes of Health Research
https://www.theroyal.ca/research
- License Information
-
More Information
Article History
Received: 10 August 2025
Accepted: 8 January 2026
First Online: 22 January 2026
Competing interests
: R.H. previously owned shares in Karuna Therapeutics Inc. and received two knowledge dissemination grants from Otsuka Canada Pharmaceutical Inc. to organize local trainee conferences. S.G. received honoraria/has been a consultant for Boehringer-Ingelheim (Canada) Ltd. C.M.C. is inventor on a patent using the methodology employed in this study that is licensed to Terran Biosciences Inc. but has not received royalties. L.T. and S.G. received a knowledge dissemination grant from Otsuka Canada Pharmaceutical Inc. and Abbvie Inc. to organize a pan-Canadian schizophrenia conference. The remaining authors have nothing to disclose.
